Edward J. Dulac III - Aug 19, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Signature
/s/ Cindy R. Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Aug 19, 2021
Transactions value $
-$306,602
Form type
4
Date filed
8/20/2021, 04:01 PM
Next filing
Sep 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Sale -$170K -1.94K -3.34% $87.90* 56.1K Aug 19, 2021 Direct F1, F2
transaction FATE Common Stock Sale -$131K -1.47K -2.63% $88.65* 54.6K Aug 19, 2021 Direct F1, F3
transaction FATE Common Stock Sale -$5.67K -63 -0.12% $90.00* 54.5K Aug 19, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 10,000 shares of Common Stock underlying RSUs granted to the reporting person on August 17, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.42 to $88.33 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.47 to $89.26 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.